The ADC binds HER2 on tumor cells, is internalized, and releases MMAE, which binds β-tubulin (vinca site) to block microtubule polymerization, causing G2/M arrest and apoptosis; killing depends on HER2 targeting (and may include ADCC), not on β-tubulin expression itself.